首页 > 最新文献

Journal of Clinical and Translational Science最新文献

英文 中文
Engaging community health center advisors to identify research priorities for health equity. 与社区卫生中心顾问合作,确定卫生公平的研究重点。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-28 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10179
Nynikka R Palmer, Michael B Potter, Saji Mansur, Cecilia Hurtado, Maria Carbajal, Gary Bossier, Maria Echaveste, Paula Fleisher, Carlos Guerra-Sanchez, Stutee Khandelwal, Gena Lewis, Lali Moheno, Tung Nguyen, David Ofman, Kerrington Osborne, James D Harrison

Background: Community health centers (CHCs) and those most burdened by disease are important partners in setting research agendas to address the needs of people who are medically underserved.

Objectives: Identify and prioritize health equity-focused research priorities using a collaborative approach to community engagement of key informants.

Methods: We used five stepwise phases from January 2021 to February 2023 to formulate and prioritize a set of health equity-focused research topics among CHC staff (leaders, clinicians), their key advisors (patients and community members), and researchers from academic medical centers in California. Phases included: (1) community advisory board formation, (2) key informant identification, (3) individual/small group interview guide development and administration, (4) initial health equity-focused topic categorization, and (5) in-person meeting with community advisors for final topic prioritization using nominal group technique.

Results: Twenty individual or small group interviews were completed with 44 diverse participants, along with engagement from our community advisory board, which resulted in an initial list of 11 health equity-focused research topics. Ninety advisors including diverse community members, CHC staff/leaders, and researchers prioritized six overarching research topics. Final prioritized health-equity focused research topics include addressing mental health challenges, improving public's trust in healthcare and science, healthcare delivery models to increase access and utilization, build and sustain an anti-racist healthcare system, strategies and interventions to address health misinformation, and continuing and sustaining polices based on lessons learned from COVID-19.

Conclusions: Results offer future direction for community-engaged research agendas to advance health equity among medically underserved and vulnerable patient populations.

背景:社区卫生中心(CHCs)和疾病负担最重的社区卫生中心是制定研究议程以解决医疗服务不足人群需求的重要合作伙伴。目标:采用协作方式,让主要举报人参与社区活动,确定以卫生公平为重点的研究重点,并确定其优先次序。方法:从2021年1月至2023年2月,我们采用五个逐步阶段,在加州CHC员工(领导者、临床医生)、他们的主要顾问(患者和社区成员)和学术医疗中心的研究人员中制定并优先考虑一系列以卫生公平为重点的研究课题。阶段包括:(1)社区咨询委员会的组建;(2)关键信息提供者的识别;(3)个人/小组访谈指导发展和管理;(4)初步以卫生公平为重点的主题分类;(5)与社区顾问面对面会议,使用名义上的小组技术确定最终的主题优先级。结果:与44名不同的参与者一起完成了20次个人或小组访谈,以及我们社区顾问委员会的参与,最终得出了11个以卫生公平为重点的研究主题的初步清单。包括不同社区成员、CHC工作人员/领导和研究人员在内的90名顾问优先考虑了六个总体研究主题。最终确定的以卫生公平为重点的优先研究课题包括:应对精神卫生挑战、提高公众对医疗保健和科学的信任、提高获取和利用的医疗保健服务模式、建立和维持反种族主义医疗保健系统、解决卫生错误信息的战略和干预措施,以及基于2019冠状病毒病的经验教训继续和维持政策。结论:结果为社区参与的研究议程提供了未来的方向,以促进医疗服务不足和弱势患者群体的健康公平。
{"title":"Engaging community health center advisors to identify research priorities for health equity.","authors":"Nynikka R Palmer, Michael B Potter, Saji Mansur, Cecilia Hurtado, Maria Carbajal, Gary Bossier, Maria Echaveste, Paula Fleisher, Carlos Guerra-Sanchez, Stutee Khandelwal, Gena Lewis, Lali Moheno, Tung Nguyen, David Ofman, Kerrington Osborne, James D Harrison","doi":"10.1017/cts.2025.10179","DOIUrl":"10.1017/cts.2025.10179","url":null,"abstract":"<p><strong>Background: </strong>Community health centers (CHCs) and those most burdened by disease are important partners in setting research agendas to address the needs of people who are medically underserved.</p><p><strong>Objectives: </strong>Identify and prioritize health equity-focused research priorities using a collaborative approach to community engagement of key informants.</p><p><strong>Methods: </strong>We used five stepwise phases from January 2021 to February 2023 to formulate and prioritize a set of health equity-focused research topics among CHC staff (leaders, clinicians), their key advisors (patients and community members), and researchers from academic medical centers in California. Phases included: (1) community advisory board formation, (2) key informant identification, (3) individual/small group interview guide development and administration, (4) initial health equity-focused topic categorization, and (5) in-person meeting with community advisors for final topic prioritization using nominal group technique.</p><p><strong>Results: </strong>Twenty individual or small group interviews were completed with 44 diverse participants, along with engagement from our community advisory board, which resulted in an initial list of 11 health equity-focused research topics. Ninety advisors including diverse community members, CHC staff/leaders, and researchers prioritized six overarching research topics. Final prioritized health-equity focused research topics include addressing mental health challenges, improving public's trust in healthcare and science, healthcare delivery models to increase access and utilization, build and sustain an anti-racist healthcare system, strategies and interventions to address health misinformation, and continuing and sustaining polices based on lessons learned from COVID-19.</p><p><strong>Conclusions: </strong>Results offer future direction for community-engaged research agendas to advance health equity among medically underserved and vulnerable patient populations.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e253"},"PeriodicalIF":2.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: EHRchitect: An open-source software tool for medical event sequences data extraction from Electronic Health Records - CORRIGENDUM. 从电子健康记录中提取医疗事件序列数据的开源软件工具-勘误表。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-28 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10183
Kostiantyn Botnar, Justin T Nguyen, Madison G Farnswort, George Golovko, Kamil Khanipov

[This corrects the article DOI: 10.1017/cts.2025.55.].

[这更正了文章DOI: 10.1017/cts.2025.55]。
{"title":"Erratum: EHRchitect: An open-source software tool for medical event sequences data extraction from Electronic Health Records - CORRIGENDUM.","authors":"Kostiantyn Botnar, Justin T Nguyen, Madison G Farnswort, George Golovko, Kamil Khanipov","doi":"10.1017/cts.2025.10183","DOIUrl":"10.1017/cts.2025.10183","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1017/cts.2025.55.].</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e242"},"PeriodicalIF":2.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing the science and practice of effective mentorship. 推进有效指导的科学和实践。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-28 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10168
Christine Pfund, Christine Sorkness, David Asai, Marcus Lambert, Emma Anne Meagher, Audrey J Murrell, Nancy Schwartz, Joel Tsevat
{"title":"Advancing the science and practice of effective mentorship.","authors":"Christine Pfund, Christine Sorkness, David Asai, Marcus Lambert, Emma Anne Meagher, Audrey J Murrell, Nancy Schwartz, Joel Tsevat","doi":"10.1017/cts.2025.10168","DOIUrl":"10.1017/cts.2025.10168","url":null,"abstract":"","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e238"},"PeriodicalIF":2.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and pilot of a tool evaluating community-engaged group processes and community-centered impact for institutional level advisory boards. 为机构级咨询委员会开发和试点一种工具,评估社区参与的小组进程和以社区为中心的影响。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-28 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10177
Michele Allen, Yasamin Graff, Caroline Carlin, Antonia Apolinario-Wilcoxon, Paulette Baukol, Kristin Boman, LaPrincess Brewer, Roli Dwivedi, Milton Eder, Susan Gust, Mikow Hang, Walter Novillo, Luis Ortega, Shannon Pergament, Chris Pulley, Rebecca Shirley, Sida Ly-Xiong

Introduction: While evaluation approaches for community-academic research groups are established, few tools exist for academic institutional advisory groups across multi-core centers and research, education, and clinical care missions. Institutional advisory group evaluation should consider group processes and their impact on community-centered outcomes. This study describes the community-engaged development of a mixed-method evaluation approach to address this gap and presents pilot outcomes across an NIH-funded center.

Methods: We utilized a Community of Practice model to co-develop a survey with 14 community and academic representatives of four advisory groups. The final survey included five categories of group process and four categories of outcomes. Storytelling sessions with community partners explored areas where the survey identified discrepancies in perspectives between community and academic team members, as well as areas with lower scores.

Results: Nine community and 14 academic (staff and faculty) partners completed the survey. Respondents positively assessed group process outcomes (shared values, leadership, community-centeredness, and decision-making), and slightly less positive assessments of institutional outcomes. Storytelling sessions confirmed the overall satisfaction of community partners but highlighted actionable concerns within power-sharing, decision-making, funding equity, and trust-building.

Conclusions: The results of this equity-centered evaluation suggest the utility and importance of participatory, mixed-methods approaches to evaluating community-academic institutional advisory groups.

虽然社区学术研究小组的评估方法已经建立,但对于跨多核心中心和研究、教育和临床护理任务的学术机构咨询小组,很少有工具存在。机构咨询小组评估应考虑小组过程及其对以社区为中心的结果的影响。本研究描述了社区参与的一种混合方法评估方法的发展,以解决这一差距,并介绍了美国国立卫生研究院资助中心的试点结果。方法:我们利用实践社区模型与四个咨询小组的14个社区和学术代表共同开发了一项调查。最后的调查包括五类小组过程和四类结果。与社区伙伴的讲故事会议探讨了调查发现社区和学术团队成员之间观点差异的领域,以及得分较低的领域。结果:9个社区和14个学术(教职员工)合作伙伴完成了调查。受访者积极评价群体过程结果(共同价值观、领导力、以社区为中心和决策),对机构结果的积极评价略低。讲故事会议确认了社区合作伙伴的总体满意度,但强调了在权力分享、决策、资金公平和建立信任方面的可操作性问题。结论:这项以公平为中心的评估结果表明,参与式、混合方法方法对评估社区-学术机构咨询小组的效用和重要性。
{"title":"Development and pilot of a tool evaluating community-engaged group processes and community-centered impact for institutional level advisory boards.","authors":"Michele Allen, Yasamin Graff, Caroline Carlin, Antonia Apolinario-Wilcoxon, Paulette Baukol, Kristin Boman, LaPrincess Brewer, Roli Dwivedi, Milton Eder, Susan Gust, Mikow Hang, Walter Novillo, Luis Ortega, Shannon Pergament, Chris Pulley, Rebecca Shirley, Sida Ly-Xiong","doi":"10.1017/cts.2025.10177","DOIUrl":"10.1017/cts.2025.10177","url":null,"abstract":"<p><strong>Introduction: </strong>While evaluation approaches for community-academic research groups are established, few tools exist for academic institutional advisory groups across multi-core centers and research, education, and clinical care missions. Institutional advisory group evaluation should consider group processes and their impact on community-centered outcomes. This study describes the community-engaged development of a mixed-method evaluation approach to address this gap and presents pilot outcomes across an NIH-funded center.</p><p><strong>Methods: </strong>We utilized a Community of Practice model to co-develop a survey with 14 community and academic representatives of four advisory groups. The final survey included five categories of group process and four categories of outcomes. Storytelling sessions with community partners explored areas where the survey identified discrepancies in perspectives between community and academic team members, as well as areas with lower scores.</p><p><strong>Results: </strong>Nine community and 14 academic (staff and faculty) partners completed the survey. Respondents positively assessed group process outcomes (shared values, leadership, community-centeredness, and decision-making), and slightly less positive assessments of institutional outcomes. Storytelling sessions confirmed the overall satisfaction of community partners but highlighted actionable concerns within power-sharing, decision-making, funding equity, and trust-building.</p><p><strong>Conclusions: </strong>The results of this equity-centered evaluation suggest the utility and importance of participatory, mixed-methods approaches to evaluating community-academic institutional advisory groups.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e261"},"PeriodicalIF":2.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing translational science through trial integrity: REDCap-based approaches to mitigating fraud and bias. 通过试验完整性推进转化科学:基于redcap的减少欺诈和偏见的方法。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-24 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10176
Gaylen E Fronk, Larry W Hawk, Andrew Cates, John Clark, Noelle Natale, Jennifer Dahne

Decentralized clinical trials (DCTs) have the potential to increase pace and reach of recruitment as well as to improve sample representation, compared to traditional in-person clinical trials. However, concerns linger regarding data integrity in DCTs due to threats of fraud and sampling bias. The purpose of this report is to describe two tools that we have developed and successfully implemented to combat these threats. Cheatblocker and QuotaConfig are two external modules that we have made publicly available within the REDCap data capture system to target fraud and sampling bias, respectively. We describe the modules, present two case examples in which we used the modules successfully, and discuss the potential impact of tools such as these on data integrity in DCTs. We situate this discussion within the broader landscape of translational science wherein we strive to improve research rigor and efficiency to maximize public health benefit.

与传统的面对面临床试验相比,分散临床试验(dct)有可能加快招募的速度和范围,并改善样本代表性。然而,由于欺诈和抽样偏差的威胁,对dct数据完整性的担忧仍然存在。本报告的目的是描述我们开发并成功实施的两种工具,以对抗这些威胁。Cheatblocker和quotacconfig是我们在REDCap数据捕获系统中公开提供的两个外部模块,分别用于针对欺诈和抽样偏差。我们描述了这些模块,给出了我们成功使用这些模块的两个案例,并讨论了这些工具对dct中数据完整性的潜在影响。我们将这一讨论置于转化科学的更广阔的前景中,其中我们努力提高研究的严密性和效率,以最大限度地提高公共卫生效益。
{"title":"Advancing translational science through trial integrity: REDCap-based approaches to mitigating fraud and bias.","authors":"Gaylen E Fronk, Larry W Hawk, Andrew Cates, John Clark, Noelle Natale, Jennifer Dahne","doi":"10.1017/cts.2025.10176","DOIUrl":"10.1017/cts.2025.10176","url":null,"abstract":"<p><p>Decentralized clinical trials (DCTs) have the potential to increase pace and reach of recruitment as well as to improve sample representation, compared to traditional in-person clinical trials. However, concerns linger regarding data integrity in DCTs due to threats of fraud and sampling bias. The purpose of this report is to describe two tools that we have developed and successfully implemented to combat these threats. Cheatblocker and QuotaConfig are two external modules that we have made publicly available within the REDCap data capture system to target fraud and sampling bias, respectively. We describe the modules, present two case examples in which we used the modules successfully, and discuss the potential impact of tools such as these on data integrity in DCTs. We situate this discussion within the broader landscape of translational science wherein we strive to improve research rigor and efficiency to maximize public health benefit.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e252"},"PeriodicalIF":2.0,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12766503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accelerating start-up cycles in investigator-initiated multicenter clinical trials. 加速研究者发起的多中心临床试验的启动周期。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-24 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10180
Shannon Hillery, Ryan Majkowski, Ying Wang, Bradley Barney, Lindsay Eyzaguirre, Andrew Mould, Nichol McBee, Esther Woo, Elizabeth Holthouse, Kenneth Wiley, Salina P Waddy, Daniel Ford, Daniel F Hanley, Karen Lane

Background: Operational roadblocks and organizational delays in multicenter clinical trials have been evident for decades, with the start-up cycle being especially notorious for setbacks. To address these challenges and improve multicenter clinical trial execution, we developed an accelerated start-up (ASU) management strategy - a structured site onboarding approach based on lean management principles.

Methods: Three elements were integrated into the strategy: a standardized workflow, a dedicated site navigator (SN), and an electronic tracking system. We examined the range, central tendencies, and distribution of site activation times among differing combinations of these three elements. To determine how these combinations affected individual start-up milestones, we fit mixed models to compare percent achievement of predetermined milestone benchmarks and time to completion.

Results: Thirteen consecutive trials (n = 308 site activations) employed three distinct combinations of the three ASU elements. Trials using all three elements (n = 6) had 160 total site activations in a median of 133 days. Three trials without the SN element had 52 total site activations in a median of 191 days. Four trials without the standardized workflow element had 96 total site activations in a median of 277 days. Significant differences between combinations included times to sIRB submission (p = 0.004), training/certificates completion (p = 0.03), and site activation (p = 0.003). Results suggest sites activated faster and achieved predetermined benchmarks for every milestone more often when three elements were employed.

Conclusion: This sample trial start-up data supports that sites can meet ambitious timelines, underscoring the strategy's potential to streamline workflows and improve site team performance.

背景:几十年来,多中心临床试验的操作障碍和组织延迟已经很明显,启动周期尤其以挫折而臭名昭著。为了应对这些挑战并改善多中心临床试验的执行,我们开发了一种加速启动(ASU)管理策略——一种基于精益管理原则的结构化站点入职方法。方法:将三个要素整合到策略中:标准化工作流程,专用站点导航器(SN)和电子跟踪系统。我们检查了这三个元素的不同组合的范围,中心趋势和站点激活时间的分布。为了确定这些组合如何影响单个启动里程碑,我们拟合混合模型来比较预定里程碑基准的实现百分比和完成时间。结果:13个连续试验(n = 308个位点激活)采用了三种不同的ASU元素组合。使用所有三种元素的试验(n = 6)在133天的中位时间内总共激活了160个位点。没有SN元件的三个试验在191天的中位时间内总共激活了52个位点。没有标准化工作流程元素的四项试验在277天的中位数内总共激活了96个站点。组合之间的显著差异包括sIRB提交时间(p = 0.004)、培训/证书完成时间(p = 0.03)和位点激活时间(p = 0.003)。结果表明,当使用三个元素时,站点激活速度更快,并且更经常地达到每个里程碑的预定基准。结论:该样本试验启动数据支持站点可以满足雄心勃勃的时间表,强调该策略在简化工作流程和提高站点团队绩效方面的潜力。
{"title":"Accelerating start-up cycles in investigator-initiated multicenter clinical trials.","authors":"Shannon Hillery, Ryan Majkowski, Ying Wang, Bradley Barney, Lindsay Eyzaguirre, Andrew Mould, Nichol McBee, Esther Woo, Elizabeth Holthouse, Kenneth Wiley, Salina P Waddy, Daniel Ford, Daniel F Hanley, Karen Lane","doi":"10.1017/cts.2025.10180","DOIUrl":"10.1017/cts.2025.10180","url":null,"abstract":"<p><strong>Background: </strong>Operational roadblocks and organizational delays in multicenter clinical trials have been evident for decades, with the start-up cycle being especially notorious for setbacks. To address these challenges and improve multicenter clinical trial execution, we developed an accelerated start-up (ASU) management strategy - a structured site onboarding approach based on lean management principles.</p><p><strong>Methods: </strong>Three elements were integrated into the strategy: a standardized workflow, a dedicated site navigator (SN), and an electronic tracking system. We examined the range, central tendencies, and distribution of site activation times among differing combinations of these three elements. To determine how these combinations affected individual start-up milestones, we fit mixed models to compare percent achievement of predetermined milestone benchmarks and time to completion.</p><p><strong>Results: </strong>Thirteen consecutive trials (<i>n</i> = 308 site activations) employed three distinct combinations of the three ASU elements. Trials using all three elements (<i>n</i> = 6) had 160 total site activations in a median of 133 days. Three trials without the SN element had 52 total site activations in a median of 191 days. Four trials without the standardized workflow element had 96 total site activations in a median of 277 days. Significant differences between combinations included times to sIRB submission (<i>p</i> = 0.004), training/certificates completion (<i>p</i> = 0.03), and site activation (<i>p</i> = 0.003). Results suggest sites activated faster and achieved predetermined benchmarks for every milestone more often when three elements were employed.</p><p><strong>Conclusion: </strong>This sample trial start-up data supports that sites can meet ambitious timelines, underscoring the strategy's potential to streamline workflows and improve site team performance.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e249"},"PeriodicalIF":2.0,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a standard operating procedure for investigational product rights of administration in clinical trials. 制定临床试验中研究产品给药权的标准操作程序。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-23 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10181
Lauren Hill, Carolynn Thomas Jones

Medication errors in clinical care and in clinical research are preventable situations requiring quality improvement approaches to mitigate negative safety trends. The "Rights of Medication Administration" framework has existed in hospital and clinic settings for decades to aid clinicians with ensuring medication administration safety for patients. These quality measures such as expanded rights of medication administration, bar coding, and "time outs" have been employed to improve clinical patient safety. In clinical trials, drug accountability standard operating procedures are established standards; however, policies for direct administration of the investigational medical product to the study participant in a trial are lacking. Current administration rights were examined through the lens of clinical research practices, regulations, and case studies leading to proposed revisions for local adaptation. The authors suggest a standard operating procedure for investigational product that includes a "time out" checklist to ensure improved quality study performance and safety for clinical trial participants. This new standard operating procedure considers evolved quality practices suggested in the new "Good Clinical Practice" guidelines, ICH E6 (R3). With safety and quality at the forefront, this newly proposed SOP has been developed for implementation at the local site. Future research is encouraged.

临床护理和临床研究中的用药错误是可预防的情况,需要质量改进方法来减轻负面的安全趋势。“用药权”框架已在医院和诊所环境中存在了几十年,以帮助临床医生确保患者用药安全。这些质量措施,如扩大药物管理权利、条形码和“暂停”,已被用于改善临床患者安全。在临床试验中,药品问责标准操作程序是既定标准;然而,缺乏对试验参与者直接施用试验性医疗产品的政策。通过临床研究实践、法规和案例研究来审查当前的管理权利,从而提出适合当地的修订建议。作者建议为研究产品制定一个标准操作程序,其中包括一个“暂停”检查表,以确保提高研究质量和临床试验参与者的安全性。这个新的标准操作程序考虑了新的“良好临床实践”指南ICH E6 (R3)中建议的质量实践。在安全和质量的最前沿,这个新提出的SOP已经在当地现场实施。鼓励未来的研究。
{"title":"Development of a standard operating procedure for investigational product rights of administration in clinical trials.","authors":"Lauren Hill, Carolynn Thomas Jones","doi":"10.1017/cts.2025.10181","DOIUrl":"10.1017/cts.2025.10181","url":null,"abstract":"<p><p>Medication errors in clinical care and in clinical research are preventable situations requiring quality improvement approaches to mitigate negative safety trends. The \"Rights of Medication Administration\" framework has existed in hospital and clinic settings for decades to aid clinicians with ensuring medication administration safety for patients. These quality measures such as expanded rights of medication administration, bar coding, and \"time outs\" have been employed to improve clinical patient safety. In clinical trials, drug accountability standard operating procedures are established standards; however, policies for direct administration of the investigational medical product to the study participant in a trial are lacking. Current administration rights were examined through the lens of clinical research practices, regulations, and case studies leading to proposed revisions for local adaptation. The authors suggest a standard operating procedure for investigational product that includes a \"time out\" checklist to ensure improved quality study performance and safety for clinical trial participants. This new standard operating procedure considers evolved quality practices suggested in the new \"Good Clinical Practice\" guidelines, ICH E6 (R3). With safety and quality at the forefront, this newly proposed SOP has been developed for implementation at the local site. Future research is encouraged.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e247"},"PeriodicalIF":2.0,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recruitment and retention in young adult health research: Motivations and barriers. 青年健康研究的招募和保留:动机和障碍。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-22 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10182
Ruixiao Wang, Julie Schweitzer, Gloria Zavala Perez, Silvia C Molina, Theresa H M Keegan

Objective: To provide insights into the motivations, challenges, and preferred methods of contact that influence the recruitment and retention of young adults (YAs) in health research.

Methods: We designed, collected, and analyzed two surveys targeting YAs aged 18-39 years through the Amazon MTurk platform, to assess factors influencing recruitment and retention in health studies. The recruitment survey (n = 477) examined initial engagement motivations, while the retention survey (n = 473) explored factors that sustain long-term participation. Descriptive analyses were stratified by age group and sex.

Results: The recruitment survey indicated that 88% of YAs were willing to participate in health studies, with a preference for online formats (78%). Social media, particularly Facebook (53%), was endorsed as the most common platform for discovering research opportunities. Monetary incentives were reported as the top motivator across all age groups, especially for those aged 35-39 years, with gift cards endorsed as the most appealing to participants aged 18-34. Retention survey results indicated that email (100%) was the most preferred method for maintaining engagement, followed by text messages (78.9%) and social media (62.2%). Text messages (65%), regular updates (56%) and sharing of study results (54%) were identified as key factors for maintaining participant engagement.

Conclusion: Our findings identify that YA participation is driven by a mix of altruistic motivations, such as contributing to the community and research, and personal motivations, including personal health benefits and financial incentives, emphasizing the need for strategies that address both aspects of recruitment and retention motivations.

目的:了解影响健康研究中年轻人(YAs)招募和保留的动机、挑战和首选联系方法。方法:我们通过亚马逊MTurk平台设计、收集并分析了两项针对18-39岁青少年的调查,以评估影响健康研究招募和保留的因素。招聘调查(n = 477)考察了最初的参与动机,而留存调查(n = 473)探讨了维持长期参与的因素。描述性分析按年龄组和性别分层。结果:招募调查显示,88%的志愿医生愿意参与健康研究,其中78%的志愿医生更倾向于在线形式。社交媒体,尤其是Facebook(53%),被认为是发现研究机会的最常见平台。据报道,在所有年龄组中,金钱奖励是最主要的激励因素,尤其是35-39岁的人,而礼品卡被认为对18-34岁的参与者最有吸引力。留存率调查结果显示,电子邮件(100%)是最受欢迎的保持用户粘性的方法,其次是短信(78.9%)和社交媒体(62.2%)。短信(65%)、定期更新(56%)和分享研究结果(54%)被认为是保持参与者参与度的关键因素。结论:我们的研究结果表明,青年学者的参与是由利他动机(如为社区和研究做出贡献)和个人动机(包括个人健康利益和财务激励)共同驱动的,强调需要解决招聘和保留动机两个方面的策略。
{"title":"Recruitment and retention in young adult health research: Motivations and barriers.","authors":"Ruixiao Wang, Julie Schweitzer, Gloria Zavala Perez, Silvia C Molina, Theresa H M Keegan","doi":"10.1017/cts.2025.10182","DOIUrl":"10.1017/cts.2025.10182","url":null,"abstract":"<p><strong>Objective: </strong>To provide insights into the motivations, challenges, and preferred methods of contact that influence the recruitment and retention of young adults (YAs) in health research.</p><p><strong>Methods: </strong>We designed, collected, and analyzed two surveys targeting YAs aged 18-39 years through the Amazon MTurk platform, to assess factors influencing recruitment and retention in health studies. The recruitment survey (<i>n</i> = 477) examined initial engagement motivations, while the retention survey (<i>n</i> = 473) explored factors that sustain long-term participation. Descriptive analyses were stratified by age group and sex.</p><p><strong>Results: </strong>The recruitment survey indicated that 88% of YAs were willing to participate in health studies, with a preference for online formats (78%). Social media, particularly Facebook (53%), was endorsed as the most common platform for discovering research opportunities. Monetary incentives were reported as the top motivator across all age groups, especially for those aged 35-39 years, with gift cards endorsed as the most appealing to participants aged 18-34. Retention survey results indicated that email (100%) was the most preferred method for maintaining engagement, followed by text messages (78.9%) and social media (62.2%). Text messages (65%), regular updates (56%) and sharing of study results (54%) were identified as key factors for maintaining participant engagement.</p><p><strong>Conclusion: </strong>Our findings identify that YA participation is driven by a mix of altruistic motivations, such as contributing to the community and research, and personal motivations, including personal health benefits and financial incentives, emphasizing the need for strategies that address both aspects of recruitment and retention motivations.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e250"},"PeriodicalIF":2.0,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695509/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Who are you going to call?:" Research ethics consultation directors' perspectives on barriers and facilitators. “你要给谁打电话?”研究伦理咨询主任对障碍和促进因素的看法。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-21 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10174
Skye A Miner, Jennifer B McCormick, Holly A Taylor

Introduction: Research ethics consultation services (RECS) provide important ethical guidance to various entities, including investigators and Institutional Review Boards. Established in the late 1980s and influenced by funding requirements from the National Center for Advancing Translational Science, RECS have evolved to address ethical challenges in research. This study aimed to identify key barriers and facilitators affecting the success of RECS, particularly in light of changes in funding and institutional support.

Materials and methods: From a comprehensive list of 55 Clinical and Translational Science Award programs, 20 RECS were purposively sampled for in-depth interviews. Interviews focused on primary functions, accomplishments, barriers, and facilitators of the service. We performed an abductive analysis on transcribed data.

Results: Twenty-two research ethics consultants from 20 institutions participated. Respondents emphasized their services' goal of facilitating ethical research, though many faced barriers such as underutilization and lack of awareness among researchers. Facilitators included institutional support and funding. Support often was contingent on institutional leadership facilitating the service into the university's research enterprise. Participants reported accomplishments, including successful consultations and contributions to institutional policies.

Discussion: Our findings indicate that RECS play a crucial role in supporting ethical research practices, though their effectiveness is often contingent on institutional relationships and funding. Key recommendations include tracking consults, defining consultation outcomes, and fostering the development of new consultants to sustain the field of research ethics.

研究伦理咨询服务(RECS)为包括研究者和机构审查委员会在内的各种实体提供重要的伦理指导。RECS成立于20世纪80年代末,受到国家促进转化科学中心资金需求的影响,已经发展到解决研究中的伦理挑战。本研究旨在确定影响RECS成功的主要障碍和促进因素,特别是考虑到资金和机构支持的变化。材料和方法:从55个临床和转化科学奖项目的综合列表中,有目的地抽取20个RECS进行深度访谈。访谈集中于服务的主要功能、成就、障碍和促进因素。我们对转录数据进行了溯因分析。结果:来自20家科研机构的22名科研伦理顾问参与。受访者强调他们的服务的目标是促进伦理研究,尽管许多面临障碍,如利用不足和缺乏意识的研究人员。促进因素包括机构支持和资金。支持往往取决于机构领导是否能促进该服务进入大学的研究事业。与会者报告了取得的成就,包括成功的协商和对体制政策的贡献。讨论:我们的研究结果表明,RECS在支持伦理研究实践方面发挥着至关重要的作用,尽管它们的有效性往往取决于机构关系和资金。主要建议包括跟踪咨询,定义咨询结果,促进新顾问的发展,以维持研究伦理领域。
{"title":"\"Who are you going to call?:\" Research ethics consultation directors' perspectives on barriers and facilitators.","authors":"Skye A Miner, Jennifer B McCormick, Holly A Taylor","doi":"10.1017/cts.2025.10174","DOIUrl":"10.1017/cts.2025.10174","url":null,"abstract":"<p><strong>Introduction: </strong>Research ethics consultation services (RECS) provide important ethical guidance to various entities, including investigators and Institutional Review Boards. Established in the late 1980s and influenced by funding requirements from the National Center for Advancing Translational Science, RECS have evolved to address ethical challenges in research. This study aimed to identify key barriers and facilitators affecting the success of RECS, particularly in light of changes in funding and institutional support.</p><p><strong>Materials and methods: </strong>From a comprehensive list of 55 Clinical and Translational Science Award programs, 20 RECS were purposively sampled for in-depth interviews. Interviews focused on primary functions, accomplishments, barriers, and facilitators of the service. We performed an abductive analysis on transcribed data.</p><p><strong>Results: </strong>Twenty-two research ethics consultants from 20 institutions participated. Respondents emphasized their services' goal of facilitating ethical research, though many faced barriers such as underutilization and lack of awareness among researchers. Facilitators included institutional support and funding. Support often was contingent on institutional leadership facilitating the service into the university's research enterprise. Participants reported accomplishments, including successful consultations and contributions to institutional policies.</p><p><strong>Discussion: </strong>Our findings indicate that RECS play a crucial role in supporting ethical research practices, though their effectiveness is often contingent on institutional relationships and funding. Key recommendations include tracking consults, defining consultation outcomes, and fostering the development of new consultants to sustain the field of research ethics.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e248"},"PeriodicalIF":2.0,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695485/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Characteristics of participants in the national research mentoring network studies - ERRATUM. 勘误:国家研究指导网络研究参与者的特征-勘误。
IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-14 eCollection Date: 2025-01-01 DOI: 10.1017/cts.2025.10167
So Hee Hyun, Emma Dums, Fátima Ruiz Sancheznieto, Kimberly Spencer, Julie M Hau, Jenna Griebel Rogers, Christine Pfund

[This corrects the article DOI: 10.1017/cts.2025.10133.].

[这更正了文章DOI: 10.1017/cts.2025.10133.]。
{"title":"Erratum: Characteristics of participants in the national research mentoring network studies - ERRATUM.","authors":"So Hee Hyun, Emma Dums, Fátima Ruiz Sancheznieto, Kimberly Spencer, Julie M Hau, Jenna Griebel Rogers, Christine Pfund","doi":"10.1017/cts.2025.10167","DOIUrl":"10.1017/cts.2025.10167","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1017/cts.2025.10133.].</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e232"},"PeriodicalIF":2.0,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695498/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical and Translational Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1